vs

Side-by-side financial comparison of AMERISAFE INC (AMSF) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $80.1M, roughly 1.9× AMERISAFE INC). AMERISAFE INC runs the higher net margin — 10.2% vs -21.1%, a 31.2% gap on every dollar of revenue. On growth, AMERISAFE INC posted the faster year-over-year revenue change (10.3% vs -19.2%). Over the past eight quarters, AMERISAFE INC's revenue compounded faster (2.8% CAGR vs -7.5%).

AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

AMSF vs OPK — Head-to-Head

Bigger by revenue
OPK
OPK
1.9× larger
OPK
$148.5M
$80.1M
AMSF
Growing faster (revenue YoY)
AMSF
AMSF
+29.5% gap
AMSF
10.3%
-19.2%
OPK
Higher net margin
AMSF
AMSF
31.2% more per $
AMSF
10.2%
-21.1%
OPK
Faster 2-yr revenue CAGR
AMSF
AMSF
Annualised
AMSF
2.8%
-7.5%
OPK

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMSF
AMSF
OPK
OPK
Revenue
$80.1M
$148.5M
Net Profit
$8.1M
$-31.3M
Gross Margin
43.1%
Operating Margin
-25.8%
Net Margin
10.2%
-21.1%
Revenue YoY
10.3%
-19.2%
Net Profit YoY
-9.0%
-322.8%
EPS (diluted)
$0.43
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMSF
AMSF
OPK
OPK
Q1 26
$80.1M
Q4 25
$81.6M
$148.5M
Q3 25
$82.0M
$151.7M
Q2 25
$81.1M
$156.8M
Q1 25
$72.6M
$150.0M
Q4 24
$74.0M
$183.6M
Q3 24
$78.7M
$173.6M
Q2 24
$75.8M
$182.2M
Net Profit
AMSF
AMSF
OPK
OPK
Q1 26
$8.1M
Q4 25
$10.4M
$-31.3M
Q3 25
$13.8M
$21.6M
Q2 25
$14.0M
$-148.4M
Q1 25
$8.9M
$-67.6M
Q4 24
$13.2M
$14.0M
Q3 24
$14.3M
$24.9M
Q2 24
$11.0M
$-10.3M
Gross Margin
AMSF
AMSF
OPK
OPK
Q1 26
Q4 25
43.1%
Q3 25
32.9%
Q2 25
31.5%
Q1 25
28.4%
Q4 24
46.1%
Q3 24
23.1%
Q2 24
28.4%
Operating Margin
AMSF
AMSF
OPK
OPK
Q1 26
Q4 25
15.6%
-25.8%
Q3 25
21.3%
31.7%
Q2 25
21.5%
-38.3%
Q1 25
15.5%
-44.8%
Q4 24
22.7%
-18.0%
Q3 24
22.6%
8.2%
Q2 24
18.1%
-33.9%
Net Margin
AMSF
AMSF
OPK
OPK
Q1 26
10.2%
Q4 25
12.8%
-21.1%
Q3 25
16.9%
14.3%
Q2 25
17.2%
-94.7%
Q1 25
12.3%
-45.1%
Q4 24
17.8%
7.6%
Q3 24
18.2%
14.3%
Q2 24
14.5%
-5.7%
EPS (diluted)
AMSF
AMSF
OPK
OPK
Q1 26
$0.43
Q4 25
$0.55
$-0.04
Q3 25
$0.72
$0.03
Q2 25
$0.73
$-0.19
Q1 25
$0.47
$-0.10
Q4 24
$0.69
$0.02
Q3 24
$0.75
$0.03
Q2 24
$0.57
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMSF
AMSF
OPK
OPK
Cash + ST InvestmentsLiquidity on hand
$34.2M
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$246.6M
$1.3B
Total Assets
$1.9B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMSF
AMSF
OPK
OPK
Q1 26
$34.2M
Q4 25
$61.9M
$364.4M
Q3 25
$54.7M
$412.0M
Q2 25
$48.5M
$267.3M
Q1 25
$44.8M
$428.8M
Q4 24
$44.1M
$426.6M
Q3 24
$63.7M
$400.1M
Q2 24
$30.6M
$40.6M
Total Debt
AMSF
AMSF
OPK
OPK
Q1 26
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Stockholders' Equity
AMSF
AMSF
OPK
OPK
Q1 26
$246.6M
Q4 25
$251.6M
$1.3B
Q3 25
$274.8M
$1.3B
Q2 25
$265.6M
$1.3B
Q1 25
$260.8M
$1.3B
Q4 24
$257.3M
$1.4B
Q3 24
$314.4M
$1.4B
Q2 24
$301.0M
$1.4B
Total Assets
AMSF
AMSF
OPK
OPK
Q1 26
Q4 25
$1.1B
$1.9B
Q3 25
$1.2B
$2.0B
Q2 25
$1.2B
$2.0B
Q1 25
$1.2B
$2.1B
Q4 24
$1.2B
$2.2B
Q3 24
$1.3B
$2.3B
Q2 24
$1.2B
$2.0B
Debt / Equity
AMSF
AMSF
OPK
OPK
Q1 26
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMSF
AMSF
OPK
OPK
Operating Cash FlowLast quarter
$-25.9M
Free Cash FlowOCF − Capex
$-28.6M
FCF MarginFCF / Revenue
-19.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMSF
AMSF
OPK
OPK
Q1 26
Q4 25
$11.1M
$-25.9M
Q3 25
$10.7M
$-34.6M
Q2 25
$-8.4M
$-83.4M
Q1 25
$-1.8M
$-34.6M
Q4 24
$24.2M
$-44.4M
Q3 24
$8.4M
$-77.1M
Q2 24
$-2.6M
$-26.4M
Free Cash Flow
AMSF
AMSF
OPK
OPK
Q1 26
Q4 25
$8.9M
$-28.6M
Q3 25
$9.8M
$-37.8M
Q2 25
$-9.5M
$-86.7M
Q1 25
$-1.8M
$-37.7M
Q4 24
$23.4M
$-49.8M
Q3 24
$8.4M
$-85.0M
Q2 24
$-2.6M
$-33.7M
FCF Margin
AMSF
AMSF
OPK
OPK
Q1 26
Q4 25
10.9%
-19.3%
Q3 25
11.9%
-24.9%
Q2 25
-11.7%
-55.3%
Q1 25
-2.5%
-25.2%
Q4 24
31.5%
-27.1%
Q3 24
10.7%
-49.0%
Q2 24
-3.5%
-18.5%
Capex Intensity
AMSF
AMSF
OPK
OPK
Q1 26
Q4 25
2.6%
1.8%
Q3 25
1.1%
2.1%
Q2 25
1.3%
2.1%
Q1 25
0.0%
2.1%
Q4 24
1.1%
2.9%
Q3 24
0.0%
4.6%
Q2 24
0.1%
4.0%
Cash Conversion
AMSF
AMSF
OPK
OPK
Q1 26
Q4 25
1.06×
Q3 25
0.77×
-1.60×
Q2 25
-0.61×
Q1 25
-0.20×
Q4 24
1.83×
-3.17×
Q3 24
0.59×
-3.10×
Q2 24
-0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMSF
AMSF

Segment breakdown not available.

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

Related Comparisons